102 results
Page 3 of 6
8-K
EX-99.1
uweom8ct
10 Nov 21
Equillium Reports Third Quarter 2021 Financial Results and Provides Clinical Development Updates
4:05pm
8-K
EX-99.1
81vgos
10 Aug 21
Equillium Reports Second Quarter 2021 Financial Results and Provides Clinical Development Update
4:11pm
8-K
EX-99.1
a64444wvew126jnbt
12 Jul 21
Regulation FD Disclosure
4:00pm
8-K
EX-99.1
nhs8ttv1 8hbvu
11 Jun 21
Equillium Announces Positive Topline Results from the EQUATE Study in First-line Treatment of Acute Graft-Versus-Host Disease
7:00am
8-K
EX-99.1
zpu6pp9ua
10 Jun 21
Regulation FD Disclosure
11:13am
8-K
EX-99.1
tcuui
7 Jun 21
Regulation FD Disclosure
3:13pm
8-K
EX-99.1
0u63d7pnqjao7m8
13 May 21
Equillium Reports First Quarter 2021 Financial Results and Provides Clinical Development Update
4:13pm
8-K
EX-99.1
rrl3efl urfo86snuhjb
30 Mar 21
Equillium Announces Favorable Data From Phase 1b EQUALISE Study in Systemic Lupus Erythematosus Patients
4:52pm
8-K
EX-99.1
w6jem7qv4
24 Mar 21
Equillium Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Clinical Development Update
4:10pm
8-K
EX-99.1
mnp x5whk31
15 Mar 21
Regulation FD Disclosure
8:02am
8-K
EX-99.1
6960b
9 Mar 21
Regulation FD Disclosure
7:00am
8-K
EX-99.2
ezdoc3dhw9j2hku
12 Feb 21
Regulation FD Disclosure
3:05pm
424B5
bthrtpd99wl6f5wo
4 Feb 21
Prospectus supplement for primary offering
8:07am
8-K
EX-99.1
icrm ribd6cu6d
7 Dec 20
Equillium Presents Translational Data Demonstrating Impact of Itolizumab on Effector T Cell
9:24am
8-K
EX-99.1
0k4s5jegfhzzlranzi
4 Dec 20
Regulation FD Disclosure
9:07am
8-K
EX-99.1
7hzqbxzpw 5b
30 Nov 20
Regulation FD Disclosure
8:01am